I can hardly comprehend what happened to me yesterday. My farewell to the @Leverpatienten on the occasion of my retirement was a more than beautiful day with members, doctors and other stakeholders.
From the bottom of my heart: thank you all! The Liver forever in my heart!
We included all (!) patients with with PBC in 🇳🇱 in this cohort. And… incidence is 🔼. Remarkable increase in proportion of 🚹 with increasing age. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study https://t.co/ahkNB55Tgg
🟪NEW Article in press❕
External validation of the IAIHG autoimmune #hepatitis response criteria in a multicentric real-world cohort
🔓#OpenAccess at 👉 https://t.co/GQiz52JzYh
#LiverTwitter
🔝This marks the 🔚of the 5️⃣ meeting of the International AIH group
1️⃣5️⃣ London 🇬🇧
1️⃣7️⃣ Newcastle 🇬🇧
1️⃣9️⃣ Vienna 🇦🇹
2️⃣2️⃣ Maastricht 🇳🇱
2️⃣4️⃣ Hannover 🇩🇪
🙏🙏 Richard Taubert @mhh_life & @BastianEngel
@jnkath @MamathaBhat3 @AlessioGerussi@Tom__gevers@macarlotal@analleo
Romée Snijders 🇳🇱 top 50 physician!
👔Which physician has the greatest significance for 🇳🇱Dutch healthcare?
@romeesnijders made it to the 🔝 5⃣0⃣
➡️connector, achiever, & maximizer par excellence
👍Well done Romée!
@Tom__gevers@ERN_RARE_LIVER
https://t.co/et8AgClYSv
OCEAN study: The first randomized controlled study to compare octreotide treatment with standard of care in patients with angiodysplasia-related bleeding @Joostphdrenth@LiaGoltstein @LucasBernts https://t.co/1Os96EgXPV
Hepatic adenomas develop and grow in response to the metabolic syndrome and obesity
Weight loss helps
1⃣@Tom__gevers case report of bariatric surgery: https://t.co/uwsZMxlPlp
2⃣Report including effect of weight loss: https://t.co/i1o90HZBfc
#livertwitter
🆕 Exciting news!! Our paper is now published online in @JHepatology!
https://t.co/oW122G4uDn
👌🏽 MMF (+steroids) is effective as first-line therapy for achieving biochemical remission in AIH
🥴 MMF: more favourable tolerability profile than AZA
@joostphdrenth@Tom__gevers